Gujarat Themis Biosyn promoter Sachin D. Patel acquires 2.29% stake via inter‑se transfer

What Gujarat Themis Biosyn announced

Gujarat Themis Biosyn Ltd (the "Company") filed a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on 1 July 2026. The filing records an inter‑se transfer of shares within the promoter group, whereby Mr. Sachin D. Patel, acting as both acquirer and promoter, increased his shareholding in the Company.

"Pursuant to Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we enclose the disclosure in relation to the change in our shareholding due to inter‑se transfer between promoters."

The transfer was executed on 30 June 2026 and reported to the stock exchanges the following day. No new shares were issued; the transaction merely re‑allocated existing shares among promoters.

Details of the inter‑se transfer

The filing provides a granular breakdown of the share movement:

• Acquirer: Sachin D. Patel (promoter / promoter group).
• Mode of acquisition: Inter‑se transfer between promoter / promoter group (off‑market).
• Date of acquisition: 30 June 2026.
• Shares acquired: 24,97,190 equity shares carrying voting rights, representing 2.29% of the total voting capital.
• Post‑transfer holding: 24,97,200 shares, still 2.29% of the total voting capital.
• Equity share capital: Remained unchanged at Rs 10,89,65,265 before and after the transfer.
• Diluted voting capital: Also unchanged at Rs 10,89,65,265.

The tables in the filing show that prior to the transfer the promoter held 10 shares (effectively negligible), and after the transfer the holding rose to 24,97,200 shares. No shares were pledged, encumbered, or subject to any convertible instruments as part of this transaction.

Key facts at a glance

Why this matters for investors

The disclosure is primarily a compliance requirement under the SEBI SAST Regulations, which mandate that any change in shareholding of 1% or more, or any transfer between promoters, be reported promptly. The key implications for shareholders are:

1. No dilution – Because the total equity share capital of the Company remains unchanged, the transfer does not dilute the economic interest of existing shareholders.
2. Promoter stake visibility – The filing makes transparent that a promoter now holds a 2.29% voting stake, which can be useful for assessing promoter commitment and influence.
3. Regulatory compliance – By filing under Reg 29(2), the Company demonstrates adherence to takeover regulations, reducing the risk of regulatory sanctions.
4. Off‑market nature – The transaction was an internal re‑allocation rather than a market purchase, meaning there was no impact on the share price or market liquidity.

Investors should note that the filing does not disclose any change in the Company’s operational outlook, financial performance, or capital structure beyond the shareholding shift.

Conclusion

Gujarat Themis Biosyn Ltd has recorded an inter‑se transfer that increased promoter Sachin D. Patel’s holding to 24.97 lakh shares, or 2.29% of the voting capital, without altering the Company’s total share capital. The filing satisfies SEBI’s disclosure requirements and provides clarity on promoter ownership. No further approvals or actions are indicated in the filing; the transaction is complete as of 30 June 2026.